Mediwhale is pleased to invite you to a special webinar designed for U.S. healthcare professionals. This webinar will introduce Oculomics, Mediwhale’s Dr. Noon products, and highlight real-world clinical experiences in medical practice.
In particular, the second session is based on the presentation invited for two consecutive years at European Society of Cardiology Congress 2025, where Mediwhale’s innovative cardiovascular risk assessment technology attracted strong attention. It will feature real outpatient cases demonstrating Dr. Noon CVD in clinical practice.
Date: 21 September 2025
Time: 03:00 PM (PT) | 06:00 PM (ET)
Sessions & Topics
- Introduction to Oculomics, Mediwhale’s Dr. Noon products (20 min)
- Findings from a two-year prospective study of outpatients, demonstrating the strong association between Dr. Noon CVD and cardiovascular disease (20 min)
- Q&A (10 min)
Speakers
Sahil Thakur MD, PhD
Head of Medical Affairs – Mediwhale
Prof Sungha Park, MD, PhD
Professor in Internal Medicine, Division of Cardiology at Severance Cardiovascular Hospital
About Dr. Noon
Dr. Noon is the world first comprehensive AI diagnostic solution to predict cardiovascular, kidney, eye diseases, and biological age through retinal images as a biomarker. Mediwhale is turning simple and effective AI diagnostic solutions into reality, empowering everyone to benefit from preventive healthcare. Dr. Noon is an investigational service, not currently cleared or approved by the U.S. FDA. The technologies described are presented for research and informational purposes only and are not intended for clinical diagnostic use.
Please register for an event meeting.
Fill out your details and we will contact you shortly.